Raftery, N.B.; Ward, M.; Ravi, N.; Reynolds, J.V.; Elliott, J.A.; Donohoe, C.L.
Modulation of the Tumour Microenvironment by HER2 in Oesophagogastric Adenocarcinoma: Implications for Tumour Progression, Therapeutic Resistance, and Clinicopathological Outcomes. Cancers 2025, 17, 3987.
https://doi.org/10.3390/cancers17243987
AMA Style
Raftery NB, Ward M, Ravi N, Reynolds JV, Elliott JA, Donohoe CL.
Modulation of the Tumour Microenvironment by HER2 in Oesophagogastric Adenocarcinoma: Implications for Tumour Progression, Therapeutic Resistance, and Clinicopathological Outcomes. Cancers. 2025; 17(24):3987.
https://doi.org/10.3390/cancers17243987
Chicago/Turabian Style
Raftery, Nicola B., Mark Ward, Narayanasamy Ravi, John V. Reynolds, Jessie A. Elliott, and Claire L. Donohoe.
2025. "Modulation of the Tumour Microenvironment by HER2 in Oesophagogastric Adenocarcinoma: Implications for Tumour Progression, Therapeutic Resistance, and Clinicopathological Outcomes" Cancers 17, no. 24: 3987.
https://doi.org/10.3390/cancers17243987
APA Style
Raftery, N. B., Ward, M., Ravi, N., Reynolds, J. V., Elliott, J. A., & Donohoe, C. L.
(2025). Modulation of the Tumour Microenvironment by HER2 in Oesophagogastric Adenocarcinoma: Implications for Tumour Progression, Therapeutic Resistance, and Clinicopathological Outcomes. Cancers, 17(24), 3987.
https://doi.org/10.3390/cancers17243987
